To identify microbial species driving pathogenic T cell responses in IBDs, we analyzed the CD4+ T cell reaction against common bacterial and fungal species of the human intestinal microbiome in patients with IBD and healthy donors (see Extended Data Tables 1 and 2 for demographic data). The gene discussed is CD4; the disease is inflammatory bowel disease.